

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
A comprehensive chart of various topical steroids, their generic and brand names, forms, and potency levels. The potency levels are categorized as very high, high, medium, lower-medium, medium (continued), low, and lowest. The document also includes notes on the classification methodology and references for further study.
Typology: Study notes
1 / 2
This page cannot be seen from the preview
Don't miss anything!
Generic Strength Brand Form VERY HIGH POTENCY betamethasone dipropionate, augmented 0.05% — oint Diprolene oint clobetasol propionate 0.05% —^ crm, emollient crm, oint, lotion, gel, soln Clobex lotion, shampoo, spray Olux (^) foam desoximetasone 0.25% Topicort spray diflorasone diacetate 0.05% —^ oint fluocinonide 0.1% Vanos crm flurandrenolide 4mcg/cm^2 Cordran^ tape halobetasol propionate 0.05% — crm, oint Lexette (^) foam Ultravate lotion 0.01% Bryhali^ lotion Duobrii* lotion HIGH POTENCY amcinonide 0.1% — oint, crm, lotion betamethasone dipropionate 0.05% — oint, crm betamethasone dipropionate, augmented 0.05% —^ crm clobetasol propionate 0.025% Impoyz crm desoximetasone 0.25% — crm, oint 0.05% — gel diflorasone diacetate 0.05% — crm fluocinonide 0.05% — crm, oint, gel, soln halcinonide 0.1% Halog crm, oint, soln mometasone furoate 0.1% —^ oint triamcinolone acetonide 0.5% — crm, oint MEDIUM POTENCY betamethasone dipropionate 0.05% Sernivo spray betamethasone valerate 0.12% Luxiq foam 0.1% — crm, oint, lotion clocortolone pivalate 0.1% Cloderm crm desoximetasone 0.05% —^ crm, oint fluocinolone acetonide 0.025% Synalar crm, oint flurandrenolide 0.05% Cordran crm, lotion, oint fluticasone propionate 0.05% — crm, lotion Cutivate (^) lotion 0.005% — oint (continued)
Generic Strength Brand Form MEDIUM POTENCY (continued) mometasone furoate 0.1% — crm, soln Elocon (^) lotion triamcinolone acetonide 0.2% Kenalog spray 0.1% — crm, oint, dental paste, lotion 0.05% — oint LOWER-MEDIUM POTENCY hydrocortisone butyrate 0.1% Locoid crm, oint hydrocortisone probutate 0.1% Pandel crm hydrocortisone valerate 0.2% — crm, oint prednicarbate 0.1% — oint triamcinolone acetonide 0.025% — crm, oint, lotion LOW POTENCY alclometasone dipropionate 0.05% — crm, oint desonide 0.05% — gel DesOwen (^) crm Verdeso (^) foam fluocinolone acetonide 0.01% Capex^ shampoo Derma-Smoothe/FS (^) oil Synalar (^) soln LOWEST POTENCY hydrocortisone acetate 2.5% Analpram HC* crm, lotion Pramosone* crm, oint, lotion 1% Analpram HC* crm Epifoam* foam Pramosone* crm, oint, lotion Proctofoam HC* foam hydrocortisone base 2.5% — crm, oint, lotion Texacort soln 1% — crm, oint, lotion NOTES *Indicates that the product has more than one active ingredient. The classification is based on vasoconstrictor assays and clinical studies. Potency varies according to the corticosteroid, its concentration, and the vehicle. In general, corticosteroids in lotions, creams, gels, and ointments are increasingly more potent due to increased absorption from these vehicles. Absorption is increased by prolonged therapy, large areas of skin damage, and the use of occlusive dressings which may cause an increase in the incidence of side effects. Not an inclusive list of medications or dosing details. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. REFERENCES Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis. American Academy of Dermatology, Inc. Published: May 07, 2014. http://dx.doi.org/10.1016/j.jaad.2014.03. Topical Steroid Potency Chart. National Psoriasis Foundation. https://www.psoriasis.org/potency-chart/. Updated December 3, 2021. Accessed January 18, 2022. (Rev. 1/2022)